{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,16]],"date-time":"2026-11-16T22:35:35Z","timestamp":1794868535089,"version":"4.9.1"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,12,3]],"date-time":"2022-12-03T00:00:00Z","timestamp":1670025600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,12,3]],"date-time":"2022-12-03T00:00:00Z","timestamp":1670025600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cardiovasc Disord"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>The diabetic heart exhibits a high sensitivity to ischaemia\/reperfusion (I\/R) injury. Diabetes mellitus (DM) can affect the efficacy of cardioprotective interventions and reduce the therapeutic potential of existing treatment options. This study aimed to investigate the feasibility of shifting from monotherapy to combination therapy in diabetic myocardial I\/R injury.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>6\u20138\u00a0week rats were randomized into 10 groups: sham, I\/R, ischaemia postconditioning (I-Post), nicorandil (Nic), combination therapy (I-Post\u2009+\u2009Nic), DM sham, DM I\/R, DM I-Post, DM Nic and DM I-Post\u2009+\u2009Nic. The extent of myocardial injury was clarified by measuring CK-MB and NO levels in plasma, ROS content in myocardial tissues, and TTC\/Evans Blue staining to assess the area of myocardial infarction. Pathological staining of cardiac tissue sections were performed to clarify the structural changes in myocardial histopathology. Finally, Western blotting was performed to detect the phosphorylation levels of some key proteins in the PI3K\/Akt signalling pathway in myocardial tissues.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>We confirms that myocardial injury in diabetic I\/R rats remained at a high level after treatment with I-Post or nicorandil alone. I-Post combined with nicorandil showed better therapeutic effects in diabetic I\/R rats, and the combined treatment further reduced the area of myocardial injury in diabetic I\/R rats compared with I-Post or nicorandil treatment alone (<jats:italic>P<\/jats:italic>\u2009&lt;\u20090.001), as well as the levels of the myocardial injury markers CK-MB and ROS (<jats:italic>P<\/jats:italic>\u2009&lt;\u20090.001); it also significantly increased plasma NO levels. Pathological staining also showed that diabetic rats benefited significantly from the combination therapy. Further mechanistic studies confirmed this finding. The protein phosphorylation levels of PI3K\/Akt signalling pathway in the heart tissue of diabetic I\/R rats were significantly higher after the combination treatment than after one treatment alone (all <jats:italic>P<\/jats:italic>\u2009&lt;\u20090.05).<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>I-Post combined with nicorandil treatment maintains effective cardioprotection against diabetic myocardial I\/R injury by activating the PI3K\/Akt signalling pathway.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12872-022-02967-1","type":"journal-article","created":{"date-parts":[[2022,12,3]],"date-time":"2022-12-03T02:02:23Z","timestamp":1670032943000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Protective effect of ischaemic postconditioning combined with nicorandil on myocardial ischaemia\u2012reperfusion injury in diabetic rats"],"prefix":"10.1186","volume":"22","author":[{"given":"Zongyi","family":"Xia","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bing","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chi","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yitian","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinyang","family":"Ren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xujin","family":"Yao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yifan","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qi","family":"Wan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhexun","family":"Lian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,12,3]]},"reference":[{"key":"2967_CR1","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1007\/5584_2020_514","volume":"1307","author":"F Maranta","year":"2021","unstructured":"Maranta F, Cianfanelli L, Cianflone D. Glycaemic control and vascular complications in diabetes mellitus type 2. Adv Exp Med Biol. 2021;1307:129\u201352.","journal-title":"Adv Exp Med Biol"},{"issue":"1","key":"2967_CR2","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1001\/jama.2015.7008","volume":"314","author":"E Di Angelantonio","year":"2015","unstructured":"Di Angelantonio E, Kaptoge S, Wormser D, Willeit P, Butterworth AS, Bansal N, O\u2019Keeffe LM, Gao P, Wood AM, Burgess S, et al. Association of cardiometabolic multimorbidity with mortality. JAMA. 2015;314(1):52\u201360.","journal-title":"JAMA"},{"key":"2967_CR3","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.yjmcc.2015.12.020","volume":"91","author":"A Lejay","year":"2016","unstructured":"Lejay A, Fang F, John R, Van JA, Barr M, Thaveau F, Chakfe N, Geny B, Scholey JW. Ischemia reperfusion injury, ischemic conditioning and diabetes mellitus. J Mol Cell Cardiol. 2016;91:11\u201322.","journal-title":"J Mol Cell Cardiol"},{"issue":"3","key":"2967_CR4","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1111\/dom.12827","volume":"19","author":"NN Gholap","year":"2017","unstructured":"Gholap NN, Achana FA, Davies MJ, Ray KK, Gray L, Khunti K. Long-term mortality after acute myocardial infarction among individuals with and without diabetes: a systematic review and meta-analysis of studies in the post-reperfusion era. Diabetes Obes Metab. 2017;19(3):364\u201374.","journal-title":"Diabetes Obes Metab"},{"issue":"6","key":"2967_CR5","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1007\/s00395-016-0588-8","volume":"111","author":"DJ Hausenloy","year":"2016","unstructured":"Hausenloy DJ, Barrabes JA, B\u00f8tker HE, Davidson SM, Di Lisa F, Downey J, Engstrom T, Ferdinandy P, Carbrera-Fuentes HA, Heusch G, et al. Ischaemic conditioning and targeting reperfusion injury: a 30 year voyage of discovery. Basic Res Cardiol. 2016;111(6):70.","journal-title":"Basic Res Cardiol"},{"issue":"2","key":"2967_CR6","doi-asserted-by":"publisher","first-page":"H579","DOI":"10.1152\/ajpheart.01064.2002","volume":"285","author":"ZQ Zhao","year":"2003","unstructured":"Zhao ZQ, Corvera JS, Halkos ME, Kerendi F, Wang NP, Guyton RA, Vinten-Johansen J. Inhibition of myocardial injury by ischemic postconditioning during reperfusion: comparison with ischemic preconditioning. Am J Physiol Heart Circ Physiol. 2003;285(2):H579-588.","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"2967_CR7","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1016\/j.ejphar.2018.06.029","volume":"833","author":"A Jovanovi\u0107","year":"2018","unstructured":"Jovanovi\u0107 A. Cardioprotective signalling: past, present and future. Eur J Pharmacol. 2018;833:314\u20139.","journal-title":"Eur J Pharmacol"},{"key":"2967_CR8","doi-asserted-by":"publisher","DOI":"10.3390\/ijms20164002","author":"A Caricati-Neto","year":"2019","unstructured":"Caricati-Neto A, Errante PR, Menezes-Rodrigues FS. Recent advances in pharmacological and non-pharmacological strategies of cardioprotection. Int J Mol Sci. 2019. https:\/\/doi.org\/10.3390\/ijms20164002.","journal-title":"Int J Mol Sci"},{"issue":"23","key":"2967_CR9","doi-asserted-by":"publisher","first-page":"5312","DOI":"10.1111\/bph.14993","volume":"177","author":"C Penna","year":"2020","unstructured":"Penna C, Andreadou I, Aragno M, Beauloye C, Bertrand L, Lazou A, Falc\u00e3o-Pires I, Bell R, Zuurbier CJ, Pagliaro P, et al. Effect of hyperglycaemia and diabetes on acute myocardial ischaemia-reperfusion injury and cardioprotection by ischaemic conditioning protocols. Br J Pharmacol. 2020;177(23):5312\u201335.","journal-title":"Br J Pharmacol"},{"key":"2967_CR10","doi-asserted-by":"publisher","first-page":"6657529","DOI":"10.1155\/2021\/6657529","volume":"2021","author":"S Gao","year":"2021","unstructured":"Gao S, Wang R, Dong S, Wu J, Perek B, Xia Z, Yao S, Wang T. Inactivation of TOPK caused by hyperglycemia blocks diabetic heart sensitivity to sevoflurane postconditioning by impairing the PTEN\/PI3K\/Akt signaling. Oxid Med Cell Longev. 2021;2021:6657529.","journal-title":"Oxid Med Cell Longev"},{"key":"2967_CR11","doi-asserted-by":"publisher","first-page":"9836302","DOI":"10.1155\/2019\/9836302","volume":"2019","author":"S Lei","year":"2019","unstructured":"Lei S, Su W, Xia ZY, Wang Y, Zhou L, Qiao S, Zhao B, Xia Z, Irwin MG. Hyperglycemia-induced oxidative stress abrogates remifentanil preconditioning-mediated cardioprotection in diabetic rats by impairing Caveolin-3-modulated PI3K\/Akt and JAK2\/STAT3 Signaling. Oxid Med Cell Longev. 2019;2019:9836302.","journal-title":"Oxid Med Cell Longev"},{"issue":"14","key":"2967_CR12","doi-asserted-by":"publisher","first-page":"1463","DOI":"10.1177\/2047487318756420","volume":"25","author":"F Saeid","year":"2018","unstructured":"Saeid F, Aniseh J, Reza B, Manouchehr VS. Signaling mediators modulated by cardioprotective interventions in healthy and diabetic myocardium with ischaemia-reperfusion injury. Eur J Prev Cardiol. 2018;25(14):1463\u201381.","journal-title":"Eur J Prev Cardiol"},{"issue":"6","key":"2967_CR13","doi-asserted-by":"publisher","first-page":"2320","DOI":"10.1159\/000374035","volume":"35","author":"H Wu","year":"2015","unstructured":"Wu H, Ye M, Yang J, Ding J, Yang J, Dong W, Wang X. Nicorandil protects the heart from ischemia\/reperfusion injury by attenuating endoplasmic reticulum response-induced apoptosis through PI3K\/Akt Signaling pathway. Cell Physiol Biochem. 2015;35(6):2320\u201332.","journal-title":"Cell Physiol Biochem"},{"issue":"8","key":"2967_CR14","doi-asserted-by":"publisher","first-page":"5349","DOI":"10.1111\/jcmm.14413","volume":"23","author":"X Wang","year":"2019","unstructured":"Wang X, Pan J, Liu D, Zhang M, Li X, Tian J, Liu M, Jin T, An F. Nicorandil alleviates apoptosis in diabetic cardiomyopathy through PI3K\/Akt pathway. J Cell Mol Med. 2019;23(8):5349\u201359.","journal-title":"J Cell Mol Med"},{"issue":"2","key":"2967_CR15","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1038\/nrendo.2017.151","volume":"14","author":"Y Zheng","year":"2018","unstructured":"Zheng Y, Ley SH, Hu FB. Global aetiology and epidemiology of type 2 diabetes mellitus and its complications. Nat Rev Endocrinol. 2018;14(2):88\u201398.","journal-title":"Nat Rev Endocrinol"},{"issue":"11","key":"2967_CR16","doi-asserted-by":"publisher","first-page":"1379","DOI":"10.1038\/aps.2012.33","volume":"33","author":"XG Li","year":"2012","unstructured":"Li XG, Li L, Zhou X, Chen Y, Ren YP, Zhou TY, Lu W. Pharmacokinetic\/pharmacodynamic studies on exenatide in diabetic rats. Acta Pharmacol Sin. 2012;33(11):1379\u201386.","journal-title":"Acta Pharmacol Sin"},{"issue":"4","key":"2967_CR17","doi-asserted-by":"publisher","first-page":"H812","DOI":"10.1152\/ajpheart.00335.2017","volume":"314","author":"ML Lindsey","year":"2018","unstructured":"Lindsey ML, Bolli R, Canty JM Jr, Du XJ, Frangogiannis NG, Frantz S, Gourdie RG, Holmes JW, Jones SP, Kloner RA, et al. Guidelines for experimental models of myocardial ischemia and infarction. Am J Physiol Heart Circ Physiol. 2018;314(4):H812-h838.","journal-title":"Am J Physiol Heart Circ Physiol"},{"issue":"4","key":"2967_CR18","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1007\/s12928-013-0182-z","volume":"28","author":"Y Suematsu","year":"2013","unstructured":"Suematsu Y, Murasato Y, Miura S, Horiuchi M, Yamamoto T, Takata K, Saku K. Safety and feasibility of high-dose administration of nicorandil before reperfusion therapy in acute myocardial infarction. Cardiovasc Interv Ther. 2013;28(4):352\u201361.","journal-title":"Cardiovasc Interv Ther"},{"issue":"2","key":"2967_CR19","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1093\/cvr\/cvw048","volume":"110","author":"Z Hu","year":"2016","unstructured":"Hu Z, Crump SM, Zhang P, Abbott GW. Kcne2 deletion attenuates acute post-ischaemia\/reperfusion myocardial infarction. Cardiovasc Res. 2016;110(2):227\u201337.","journal-title":"Cardiovasc Res"},{"key":"2967_CR20","doi-asserted-by":"publisher","DOI":"10.3791\/56672","author":"C Nagy","year":"2018","unstructured":"Nagy C, Einwallner E. Study of in vivo glucose metabolism in high-fat diet-fed mice using Oral Glucose Tolerance Test (OGTT) and Insulin Tolerance Test (ITT). J Vis Exp. 2018. https:\/\/doi.org\/10.3791\/56672.","journal-title":"J Vis Exp"},{"issue":"8","key":"2967_CR21","doi-asserted-by":"publisher","first-page":"987","DOI":"10.1161\/01.CIR.0000027109.14149.67","volume":"106","author":"KY Lin","year":"2002","unstructured":"Lin KY, Ito A, Asagami T, Tsao PS, Adimoolam S, Kimoto M, Tsuji H, Reaven GM, Cooke JP. Impaired nitric oxide synthase pathway in diabetes mellitus: role of asymmetric dimethylarginine and dimethylarginine dimethylaminohydrolase. Circulation. 2002;106(8):987\u201392.","journal-title":"Circulation"},{"issue":"11","key":"2967_CR22","doi-asserted-by":"publisher","first-page":"743","DOI":"10.1089\/dna.2014.2352","volume":"33","author":"R Anuradha","year":"2014","unstructured":"Anuradha R, Saraswati M, Kumar KG, Rani SH. Apoptosis of beta cells in diabetes mellitus. DNA Cell Biol. 2014;33(11):743\u20138.","journal-title":"DNA Cell Biol"},{"key":"2967_CR23","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1186\/1475-2840-12-158","volume":"12","author":"ZW Liu","year":"2013","unstructured":"Liu ZW, Zhu HT, Chen KL, Dong X, Wei J, Qiu C, Xue JH. Protein kinase RNA-like endoplasmic reticulum kinase (PERK) signaling pathway plays a major role in reactive oxygen species (ROS)-mediated endoplasmic reticulum stress-induced apoptosis in diabetic cardiomyopathy. Cardiovasc Diabetol. 2013;12:158.","journal-title":"Cardiovasc Diabetol"},{"issue":"2","key":"2967_CR24","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.113.000679","volume":"3","author":"S Limalanathan","year":"2014","unstructured":"Limalanathan S, Andersen G, Kl\u00f8w NE, Abdelnoor M, Hoffmann P, Eritsland J. Effect of ischemic postconditioning on infarct size in patients with ST-elevation myocardial infarction treated by primary PCI results of the POSTEMI (POstconditioning in ST-elevation myocardial infarction) randomized trial. J Am Heart Assoc. 2014;3(2): e000679.","journal-title":"J Am Heart Assoc"},{"issue":"5","key":"2967_CR25","doi-asserted-by":"publisher","first-page":"490","DOI":"10.1001\/jamacardio.2017.0022","volume":"2","author":"T Engstr\u00f8m","year":"2017","unstructured":"Engstr\u00f8m T, Kelb\u00e6k H, Helqvist S, H\u00f8fsten DE, Kl\u00f8vgaard L, Clemmensen P, Holmvang L, J\u00f8rgensen E, Pedersen F, Saunamaki K, et al. Effect of ischemic postconditioning during primary percutaneous coronary intervention for patients With ST-segment elevation myocardial infarction: a randomized clinical trial. JAMA Cardiol. 2017;2(5):490\u20137.","journal-title":"JAMA Cardiol"},{"issue":"3","key":"2967_CR26","doi-asserted-by":"publisher","DOI":"10.1002\/adhm.202001571","volume":"10","author":"F Poustchi","year":"2021","unstructured":"Poustchi F, Amani H, Ahmadian Z, Niknezhad SV, Mehrabi S, Santos HA, Shahbazi MA. Combination therapy of killing diseases by injectable hydrogels: from concept to medical applications. Adv Healthc Mater. 2021;10(3): e2001571.","journal-title":"Adv Healthc Mater"},{"key":"2967_CR27","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2020.110121","volume":"127","author":"B Zhan","year":"2020","unstructured":"Zhan B, Xu Z, Zhang Y, Wan K, Deng H, Wang D, Bao H, Wu Q, Hu X, Wang H, et al. Nicorandil reversed homocysteine-induced coronary microvascular dysfunction via regulating PI3K\/Akt\/eNOS pathway. Biomed Pharmacother. 2020;127: 110121.","journal-title":"Biomed Pharmacother"},{"issue":"6","key":"2967_CR28","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1177\/1074248416636477","volume":"21","author":"MZ Afzal","year":"2016","unstructured":"Afzal MZ, Reiter M, Gastonguay C, McGivern JV, Guan X, Ge ZD, Mack DL, Childers MK, Ebert AD, Strande JL. Nicorandil, a nitric oxide donor and ATP-sensitive potassium channel opener, protects against dystrophin-deficient cardiomyopathy. J Cardiovasc Pharmacol Ther. 2016;21(6):549\u201362.","journal-title":"J Cardiovasc Pharmacol Ther"},{"issue":"1","key":"2967_CR29","first-page":"26","volume":"45","author":"ZQ Wang","year":"2017","unstructured":"Wang ZQ, Chen MX, Liu DL, Zheng WX, Cao XZ, Chen H, Huang MF, Luo ZR. The effect on myocardial perfusion and clinical outcome of intracoronary nicorandil injection prior to percutaneous coronary intervention in ST-segment elevation myocardial infarction. Zhonghua Xin Xue Guan Bing Za Zhi. 2017;45(1):26\u201333.","journal-title":"Zhonghua Xin Xue Guan Bing Za Zhi"},{"issue":"1","key":"2967_CR30","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1186\/s12872-019-1071-x","volume":"19","author":"XT Zhao","year":"2019","unstructured":"Zhao XT, Zhang CF, Liu QJ. Meta-analysis of Nicorandil effectiveness on myocardial protection after percutaneous coronary intervention. BMC Cardiovasc Disord. 2019;19(1):144.","journal-title":"BMC Cardiovasc Disord"},{"issue":"10","key":"2967_CR31","doi-asserted-by":"publisher","first-page":"647","DOI":"10.21037\/atm-20-3768","volume":"8","author":"G Zhao","year":"2020","unstructured":"Zhao G, Zhang X, Wang H, Chen Z. Beta carotene protects H9c2 cardiomyocytes from advanced glycation end product-induced endoplasmic reticulum stress, apoptosis, and autophagy via the PI3K\/Akt\/mTOR signaling pathway. Ann Transl Med. 2020;8(10):647.","journal-title":"Ann Transl Med"},{"issue":"1","key":"2967_CR32","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1186\/s40200-014-0106-1","volume":"13","author":"M Najafi","year":"2014","unstructured":"Najafi M, Farajnia S, Mohammadi M, Badalzadeh R, Ahmadi Asl N, Baradaran B, Amani M. Inhibition of mitochondrial permeability transition pore restores the cardioprotection by postconditioning in diabetic hearts. J Diabetes Metab Disord. 2014;13(1):106.","journal-title":"J Diabetes Metab Disord"},{"issue":"6","key":"2967_CR33","doi-asserted-by":"publisher","first-page":"763","DOI":"10.1038\/aps.2016.14","volume":"37","author":"F He","year":"2016","unstructured":"He F, Xu BL, Chen C, Jia HJ, Wu JX, Wang XC, Sheng JL, Huang L, Cheng J. Methylophiopogonanone A suppresses ischemia\/reperfusion-induced myocardial apoptosis in mice via activating PI3K\/Akt\/eNOS signaling pathway. Acta Pharmacol Sin. 2016;37(6):763\u201371.","journal-title":"Acta Pharmacol Sin"},{"issue":"1","key":"2967_CR34","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1152\/physrev.00036.2017","volume":"99","author":"J Tejero","year":"2019","unstructured":"Tejero J, Shiva S, Gladwin MT. Sources of vascular nitric oxide and reactive oxygen species and their regulation. Physiol Rev. 2019;99(1):311\u201379.","journal-title":"Physiol Rev"},{"issue":"1","key":"2967_CR35","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCHEARTFAILURE.115.002424","volume":"9","author":"SL Baumgardt","year":"2016","unstructured":"Baumgardt SL, Paterson M, Leucker TM, Fang J, Zhang DX, Bosnjak ZJ, Warltier DC, Kersten JR, Ge ZD. Chronic co-administration of sepiapterin and l-citrulline ameliorates diabetic cardiomyopathy and myocardial ischemia\/reperfusion injury in obese type 2 diabetic mice. Circ Heart Fail. 2016;9(1): e002424.","journal-title":"Circ Heart Fail"},{"key":"2967_CR36","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/j.niox.2014.08.004","volume":"43","author":"S Khanna","year":"2014","unstructured":"Khanna S, Singh GB, Khullar M. Nitric oxide synthases and diabetic cardiomyopathy. Nitric Oxide. 2014;43:29\u201334.","journal-title":"Nitric Oxide"},{"issue":"2","key":"2967_CR37","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1016\/j.pharmthera.2007.06.005","volume":"116","author":"DJ Hausenloy","year":"2007","unstructured":"Hausenloy DJ, Yellon DM. Preconditioning and postconditioning: united at reperfusion. Pharmacol Ther. 2007;116(2):173\u201391.","journal-title":"Pharmacol Ther"},{"issue":"1","key":"2967_CR38","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1007\/s13105-016-0530-4","volume":"73","author":"R Badalzadeh","year":"2017","unstructured":"Badalzadeh R, Azimi A, Alihemmati A, Yousefi B. Chronic type-I diabetes could not impede the anti-inflammatory and anti-apoptotic effects of combined postconditioning with ischemia and cyclosporine A in myocardial reperfusion injury. J Physiol Biochem. 2017;73(1):111\u201320.","journal-title":"J Physiol Biochem"},{"key":"2967_CR39","doi-asserted-by":"publisher","DOI":"10.3390\/ijms22115973","author":"P Grubi\u0107 Rotkvi\u0107","year":"2021","unstructured":"Grubi\u0107 Rotkvi\u0107 P, Planini\u0107 Z, Liberati Pr\u0161o AM, \u0160iki\u0107 J, Gali\u0107 E, Rotkvi\u0107 L. The mystery of diabetic cardiomyopathy: from early concepts and underlying mechanisms to novel therapeutic possibilities. Int J Mol Sci. 2021. https:\/\/doi.org\/10.3390\/ijms22115973.","journal-title":"Int J Mol Sci"},{"issue":"2","key":"2967_CR40","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1093\/cvr\/cvv171","volume":"107","author":"JJ Alburquerque-B\u00e9jar","year":"2015","unstructured":"Alburquerque-B\u00e9jar JJ, Barba I, Inserte J, Mir\u00f3-Casas E, Ruiz-Meana M, Poncelas M, Vilardosa \u00da, Valls-Lacalle L, Rodr\u00edguez-Sinovas A, Garcia-Dorado D. Combination therapy with remote ischaemic conditioning and insulin or exenatide enhances infarct size limitation in pigs. Cardiovasc Res. 2015;107(2):246\u201354.","journal-title":"Cardiovasc Res"},{"issue":"1","key":"2967_CR41","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1007\/s00395-021-00842-2","volume":"116","author":"B Garc\u00eda Del Blanco","year":"2021","unstructured":"Garc\u00eda Del Blanco B, Otaegui I, Rodr\u00edguez-Palomares JF, Bay\u00e9s-Genis A, Fern\u00e1ndez-Nofrer\u00edas E, Vilalta Del Olmo V, Carrillo X, Ib\u00e1\u00f1ez B, Worner F, Casanova J, et al. Effect of COMBinAtion therapy with remote ischemic conditioning and exenatide on the Myocardial Infarct size: a two-by-two factorial randomized trial (COMBAT-MI). Basic Res Cardiol. 2021;116(1):4.","journal-title":"Basic Res Cardiol"},{"issue":"7","key":"2967_CR42","doi-asserted-by":"publisher","first-page":"e3000410","DOI":"10.1371\/journal.pbio.3000410","volume":"18","author":"N Percie du Sert","year":"2020","unstructured":"Percie du Sert N, Hurst V, Ahluwalia A, Alam S, Avey MT, Baker M, Browne WJ, Clark A, Cuthill IC, Dirnagl U, et al. The ARRIVE guidelines 2.0: updated guidelines for reporting animal research. PLoS Biol. 2020;18(7):e3000410.","journal-title":"PLoS Biol"}],"container-title":["BMC Cardiovascular Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12872-022-02967-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12872-022-02967-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12872-022-02967-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,4]],"date-time":"2022-12-04T18:02:21Z","timestamp":1670176941000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmccardiovascdisord.biomedcentral.com\/articles\/10.1186\/s12872-022-02967-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12,3]]},"references-count":42,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["2967"],"URL":"https:\/\/doi.org\/10.1186\/s12872-022-02967-1","relation":{},"ISSN":["1471-2261"],"issn-type":[{"value":"1471-2261","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,12,3]]},"assertion":[{"value":"5 April 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 November 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 December 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This project fully protects the rights and interests of rats. All experiments were performed in accordance with relevant guidelines and regulations, and the manuscript report complied with the ARRIVE guidelines for animal experiment reporting []. The study has passed the requirements of the Laboratory Animal Welfare Ethics Committee of Qingdao University, Lot NO. 20200812SD25020201230002.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for Publication"}},{"value":"The authors confirm that there are no conflicts of interest.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"518"}}